“By only considering the end product it means that our participation has always been in vain”

Debates about what constitutes benefits in human research continue to be less informed due to a lack of empirical evidence from the developing world. This study aimed to explore what constitutes benefits in HIV vaccine trials in Tanzania and examine inherent ethical implications. A qualitative case study design was deployed and a total of 29 purposively selected study participants comprising of experienced researchers, institutional review board members and community advisory board members were included. Collected data were analyzed by thematic analysis aided by computer software: MAXQDA version 20.4.0. The study findings indicate that there is a growing appreciation of benefits beyond actual vaccines to include 1) capacity building at individual, community, institutional and regulatory levels; and 2) non‐capacity building related benefits such as strengthened collaborations, ancillary care and employment opportunities. So, as the struggle for viable HIV vaccines continues, other benefits that have accrued from such trials are not to be blindsided especially for developing countries like Tanzania

Business · Capacity building · Clinical trial · Developing country · Economic growth · Economics · Family medicine · HIV vaccine · Institutional review board · Political science · Public relations · Qualitative research · Research ethics · Social science · Socioeconomics · Sociology · Tanzania · Thematic analysis · Vaccine trial · Ethics in Clinical Research · Medicine · Vaccine Coverage and Hesitancy · Viral Infections and Outbreaks Research